208 related articles for article (PubMed ID: 27821613)
1. Use of injectable hormonal contraception and HSV-2 acquisition in a cohort of female sex workers in Vancouver, Canada.
Socías ME; Duff P; Shoveller J; Montaner JSG; Nguyen P; Ogilvie G; Shannon K
Sex Transm Infect; 2017 Jun; 93(4):284-289. PubMed ID: 27821613
[TBL] [Abstract][Full Text] [Related]
2. Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda.
Grabowski MK; Gray RH; Makumbi F; Kagaayi J; Redd AD; Kigozi G; Reynolds SJ; Nalugoda F; Lutalo T; Wawer MJ; Serwadda D; Quinn TC; Tobian AAR
Lancet Glob Health; 2015 Aug; 3(8):e478-e486. PubMed ID: 26094162
[TBL] [Abstract][Full Text] [Related]
3. Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
Noguchi LM; Richardson BA; Baeten JM; Hillier SL; Balkus JE; Chirenje ZM; Bunge K; Ramjee G; Nair G; Palanee-Phillips T; Selepe P; van der Straten A; Parikh UM; Gomez K; Piper JM; Watts DH; Marrazzo JM;
Lancet HIV; 2015 Jul; 2(7):e279-87. PubMed ID: 26155597
[TBL] [Abstract][Full Text] [Related]
4. Hormonal contraception and HIV acquisition risk: implications for individual users and public policies.
Jain AK
Contraception; 2012 Dec; 86(6):645-52. PubMed ID: 22541635
[TBL] [Abstract][Full Text] [Related]
5. Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial.
Mugo NR; Stalter RM; Heffron R; Rees H; Scoville CW; Morrison C; Kourtis AP; Bukusi E; Beksinka M; Philip NM; Beesham I; Deese J; Edward V; Donnell D; Baeten JM;
Clin Infect Dis; 2022 Sep; 75(4):586-595. PubMed ID: 34910143
[TBL] [Abstract][Full Text] [Related]
6. Effects of hormonal contraceptive use on HIV acquisition and transmission among HIV-discordant couples.
Lutalo T; Musoke R; Kong X; Makumbi F; Serwadda D; Nalugoda F; Kigozi G; Sewankambo N; Sekasanvu J; Wawer M; Gray R
AIDS; 2013 Oct; 27 Suppl 1():S27-34. PubMed ID: 24088681
[TBL] [Abstract][Full Text] [Related]
7. Responding to the ECHO trial results: modelling the potential impact of changing contraceptive method mix on HIV and reproductive health in South Africa.
Smith JA; Beacroft L; Abdullah F; Buthelezi B; Makua M; Morroni C; Ramjee G; Velasquez C; Hallett TB
J Int AIDS Soc; 2020 Oct; 23(10):e25620. PubMed ID: 33030312
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and Incidence of Sexually Transmitted Infection in Injectable Progestin Contraception Users in South Africa.
Noguchi LM; Marrazzo JM; Richardson B; Hillier SL; Balkus JE; Palanee-Phillips T; Nair G; Panchia R; Piper J; Gomez K; Ramjee G; Chirenje ZM
Front Reprod Health; 2021 Jul; 3():. PubMed ID: 35669097
[TBL] [Abstract][Full Text] [Related]
9. Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis.
Morrison CS; Chen PL; Kwok C; Baeten JM; Brown J; Crook AM; Van Damme L; Delany-Moretlwe S; Francis SC; Friedland BA; Hayes RJ; Heffron R; Kapiga S; Karim QA; Karpoff S; Kaul R; McClelland RS; McCormack S; McGrath N; Myer L; Rees H; van der Straten A; Watson-Jones D; van de Wijgert JH; Stalter R; Low N
PLoS Med; 2015 Jan; 12(1):e1001778. PubMed ID: 25612136
[TBL] [Abstract][Full Text] [Related]
10. Increased Cervical CD4
Lajoie J; Tjernlund A; Omollo K; Edfeldt G; Röhl M; Boily-Larouche G; Cheruiyot J; Kimani M; Kimani J; Oyugi J; Broliden K; Fowke KR
AIDS Res Hum Retroviruses; 2019 Mar; 35(3):236-246. PubMed ID: 30585733
[TBL] [Abstract][Full Text] [Related]
11. Hormonal contraception and the risk of HIV acquisition.
Morrison CS; Richardson BA; Mmiro F; Chipato T; Celentano DD; Luoto J; Mugerwa R; Padian N; Rugpao S; Brown JM; Cornelisse P; Salata RA;
AIDS; 2007 Jan; 21(1):85-95. PubMed ID: 17148972
[TBL] [Abstract][Full Text] [Related]
12. Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture.
Lanza LL; McQuay LJ; Rothman KJ; Bone HG; Kaunitz AM; Harel Z; Ataher Q; Ross D; Arena PL; Wolter KD
Obstet Gynecol; 2013 Mar; 121(3):593-600. PubMed ID: 23635623
[TBL] [Abstract][Full Text] [Related]
13. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women.
Baeten JM; Benki S; Chohan V; Lavreys L; McClelland RS; Mandaliya K; Ndinya-Achola JO; Jaoko W; Overbaugh J
AIDS; 2007 Aug; 21(13):1771-7. PubMed ID: 17690576
[TBL] [Abstract][Full Text] [Related]
14. Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity.
Zalenskaya IA; Chandra N; Yousefieh N; Fang X; Adedipe OE; Jackson SS; Anderson SM; Mauck CK; Schwartz JL; Thurman AR; Doncel GF
J Clin Invest; 2018 Oct; 128(10):4622-4638. PubMed ID: 30222141
[TBL] [Abstract][Full Text] [Related]
15. Hormonal Contraception and Risk of Psychiatric and Other Noncommunicable Diseases in HIV-Infected Women.
Castilho JL; Jenkins CA; Shepherd BE; Bebawy SS; Turner M; Sterling TR; Melekhin VV
J Womens Health (Larchmt); 2015 Jun; 24(6):481-8. PubMed ID: 25751720
[TBL] [Abstract][Full Text] [Related]
16. The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK.
Kyvernitakis I; Kostev K; Nassour T; Thomasius F; Hadji P
Osteoporos Int; 2017 Jan; 28(1):291-297. PubMed ID: 27461017
[TBL] [Abstract][Full Text] [Related]
17. Contraceptive Use and Pregnancy Incidence Among Women Participating in an HIV Prevention Trial.
Akello CA; Bunge KE; Nakabiito C; Mirembe BG; Fowler MG; Mishra A; Marrazzo J; Chirenje ZM; Celum C; Balkus JE
J Womens Health (Larchmt); 2017 Jun; 26(6):670-676. PubMed ID: 28437215
[TBL] [Abstract][Full Text] [Related]
18. Objective Measurement of Inaccurate Condom Use Reporting Among Women Using Depot Medroxyprogesterone Acetate for Contraception.
Heffron R; Parikh UM; Penrose KJ; Mugo N; Donnell D; Celum C; Mellors JW; Baeten JM;
AIDS Behav; 2017 Jul; 21(7):2173-2179. PubMed ID: 27699594
[TBL] [Abstract][Full Text] [Related]
19. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
20. Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial.
Crook AM; Ford D; Gafos M; Hayes R; Kamali A; Kapiga S; Nunn A; Chisembele M; Ramjee G; Rees H; McCormack S
Hum Reprod; 2014 Aug; 29(8):1810-7. PubMed ID: 24838704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
